ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Ovarian Cancer
Non-Small-Cell Lung Carcinoma
Breast Cancer
Cancer
Colorectal Cancer
Uterine Cervical Cancer
Stomach Cancer

Endometrial Cancer trials near San Antonio, TX, USA:

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

and safety of T-DXd adjuvant therapy, with or without radiotherapy, post-surgery in anticancer treatment naïve (including neoadjuvant therapy) endometrial...

Enrolling
Endometrial Cancer
Drug: Trastuzumab Deruxtecan
Drug: Chemotherapy

Phase 3

Daiichi Sankyo
Daiichi Sankyo

San Antonio, Texas, United States and 60 other locations

This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...

Active, not recruiting
Endometrial Cancer
Drug: INCAGN02385
Drug: pemigatinib

Phase 2

Incyte
Incyte

San Antonio, Texas, United States and 66 other locations

DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when com...

Enrolling
Endometrial Cancer
Drug: Carboplatin
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

San Antonio, Texas, United States and 248 other locations

Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...

Active, not recruiting
Endometrial Cancer
Drug: Paclitaxel
Drug: Rescue medications

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

San Antonio, Texas, United States and 242 other locations

This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have ...

Enrolling
Endometrial Cancer
Drug: Navtemadlin
Drug: Navtemadlin Placebo

Phase 2, Phase 3

Kartos Therapeutics
Kartos Therapeutics

San Antonio, Texas, United States and 82 other locations

Locations recently updated

(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...

Active, not recruiting
Endometrial Neoplasms
Drug: Carboplatin
Biological: durvalumab

Phase 3

AstraZeneca
AstraZeneca

San Antonio, Texas, United States and 201 other locations

standard medical care for the treatment of recurrent or progressive endometrial cancer (EC) following prior therapy. There is an eq...

Enrolling
Endometrial Cancer
Recurrent or Progressive Endometrial Cancer
Drug: Rina-S
Drug: IC

Phase 3

Genmab
Genmab

San Antonio, Texas, United States and 73 other locations

drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...

Active, not recruiting
Endometrial Cancer
Breast Cancer
Drug: Trastuzumab
Drug: Everolimus

Phase 1

Lilly
Lilly

San Antonio, Texas, United States of America and 73 other locations

(ADC), in adult participants with advanced or metastatic solid tumors known to be expressing PTK7. The study employs a sequential dose escal...

Enrolling
Endometrial Cancer
Ovarian Cancer Metastatic Recurrent
Drug: HWK-007

Phase 1

Whitehawk Therapeutics, Inc.

San Antonio, Texas, United States and 11 other locations

Locations recently updated

Researchers are looking for new ways to treat people with proficient mismatch repair (pMMR) endometrial cancer (EC) that is advance...

Enrolling
Endometrial Cancer
Drug: Carboplatin
Biological: Pembrolizumab

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

San Antonio, Texas, United States and 251 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems